A method is disclosed for producing a polypeptide with a modified activity or stability, by replacing an arginine residue capable of being ADP-ribosylated with a tryptophan or a phenylalanine. In one embodiment, compositions are provided that include polypeptides, such as alpha defensin, with arginine-to-tryptophan or arginine-to-phenylalanine substitutions, where the arginine residue is capable of being ADP-ribosylated. In another embodiment, methods are disclosed for modifying an immune response in a subject.

 
Web www.patentalert.com

< Administration of 5T4 antigen and immune response of cells expressing 5T4 and CEA antigens

> Cleavage of nucleic acids

> Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease

~ 00524